polycoretherapeutics.com | PolyCore Therapeutics – A Breakthrough for Parkinson’s Disease

Robots.txt Information

Robot	Path	Permission
GoogleBot	/	✔
BingBot	/	✔
BaiduSpider	/	✔
YandexBot	/	✔
User-agent: * Disallow: /wp-admin/ Allow: /wp-admin/admin-ajax.php Sitemap: https://polycoretherapeutics.com/wp-sitemap.xml

Meta Tags

Title	PolyCore Therapeutics – A Breakthrough for Parkinson’s Disease
Description	Our Science Pipeline Team About News Contact Menu Our Science Pipeline Team About News Contact Developing breakthrough treatment for dyskinesia PolyCore i
Keywords	N/A

Server Information

WebSite	polycoretherapeutics.com
Host IP	172.67.182.114
Location	United States

Related Websites

                        Site
                        Rank
                    

More to Explore

polycoretherapeutics.com Valuation

US$1,737,300

Last updated: 2022-07-06 23:40:35

polycoretherapeutics.com has Semrush global rank of 6,092,388. polycoretherapeutics.com has an estimated worth of US$ 1,737,300, based on its estimated Ads revenue. polycoretherapeutics.com receives approximately 200,458 unique visitors each day. Its web server is located in United States, with IP address 172.67.182.114. According to SiteAdvisor, polycoretherapeutics.com is safe to visit.

Traffic & Worth Estimates

Purchase/Sale Value	US$1,737,300
Daily Ads Revenue	US$1,604
Monthly Ads Revenue	US$48,110
Yearly Ads Revenue	US$577,319
Daily Unique Visitors	13,364
Note: All traffic and earnings values are estimates.

DNS Records

Host	Type	TTL	Data
polycoretherapeutics.com. 299	A	polycoretherapeutics.com. 299	IP: 172.67.182.114
polycoretherapeutics.com. 299	A	polycoretherapeutics.com. 299	IP: 104.21.59.188
polycoretherapeutics.com. 299	AAAA	polycoretherapeutics.com. 299	IPV6: 2606:4700:3030::ac43:b672
polycoretherapeutics.com. 299	AAAA	polycoretherapeutics.com. 299	IPV6: 2606:4700:3033::6815:3bbc
polycoretherapeutics.com. 86400	NS	polycoretherapeutics.com. 86400	NS Record: angela.ns.cloudflare.com.
polycoretherapeutics.com. 86400	NS	polycoretherapeutics.com. 86400	NS Record: sid.ns.cloudflare.com.
polycoretherapeutics.com. 3600	MX	polycoretherapeutics.com. 3600	MX Record: 0 polycoretherapeutics-com.mail.protection.outlook.com.
polycoretherapeutics.com. 3600	TXT	polycoretherapeutics.com. 3600	TXT Record: v=spf1 include:spf.protection.outlook.com ~all
polycoretherapeutics.com. 3600	TXT	polycoretherapeutics.com. 3600	TXT Record: MS=ms84490658

HtmlToTextCheckTime:2022-07-06 23:40:35

Our Science Pipeline Team About News Contact Menu Our Science Pipeline Team About News Contact Developing breakthrough treatment for dyskinesia PolyCore is committed to applying novel science to give patients with Parkinson’s Disease and other CNS disorders better quality of life. Learn How Our lead compound, PCT-3012, targets dyskinesia and cognitive impairment associated with neurodegenerative disorders and is currently in preclinical studies for treatment of motor symptoms and dyskinesia in patients with early- to mid-stage Parkinson’s Disease (PD). View Our Pipeline Advancing PCT-3012 for Levodopa-Induced Dyskinesia PolyCore’s PCT-3012 novel dopamine D3 receptor agonist is designed to modify how L-dopa works instead of negating its effects, to improve motor symptoms without the development of tolerance, dyskinesia or impulsive behaviors. Explore the science Did You Know? Levodopa (L-dopa), discovered in the late 1960s, is still the gold standard gold standard for treating PD

HTTP Headers

HTTP/1.1 301 Moved Permanently
Date: Fri, 29 Oct 2021 16:43:12 GMT
Content-Type: text/html
Connection: keep-alive
location: https://polycoretherapeutics.com/
CF-Cache-Status: DYNAMIC
Report-To: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=1HFPWZGWComG%2BbWynr9guebHDvovgkCaL1n50If1KhqrI3YaODuLrc0rjU6fCjKOA6czaxLZxFBJFym49F6AcNko8%2B7lN8LZyegy18vI9m7uN78setzcdCWZfuRIRAjuAUodE8qajUhsY2I%3D"}],"group":"cf-nel","max_age":604800}
NEL: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
Server: cloudflare
CF-RAY: 6a5ddc8b78c40347-ORD
alt-svc: h3=":443"; ma=86400, h3-29=":443"; ma=86400, h3-28=":443"; ma=86400, h3-27=":443"; ma=86400

HTTP/2 200 
date: Fri, 29 Oct 2021 16:43:13 GMT
content-type: text/html; charset=UTF-8
vary: Accept-Encoding
link: ; rel="https://api.w.org/", ; rel="alternate"; type="application/json", ; rel=shortlink
x-frame-options: SAMEORIGIN
x-xss-protection: 1; mode=block
x-content-type-options: nosniff
cf-cache-status: DYNAMIC
expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct"
report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=vq%2FV2hMIYwre7GU3zRysCGO0lppgem1x1OUjOErT5A4%2F3uVO1tJb5S9QpSEDNYxbOaWebsT4g2lNGUE5PRdBk%2FfTqvMDUTmCmcVTxrs8QTwMxjRGcUbFp%2FXK8Q8YQGmAVj5NGq%2B18ty2KVU%3D"}],"group":"cf-nel","max_age":604800}
nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800}
server: cloudflare
cf-ray: 6a5ddc8c3ce02ac6-ORD
alt-svc: h3=":443"; ma=86400, h3-29=":443"; ma=86400, h3-28=":443"; ma=86400, h3-27=":443"; ma=86400

polycoretherapeutics.com Whois Information

Domain Name: POLYCORETHERAPEUTICS.COM
Registry Domain ID: 2003788748_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.cloudflare.com
Registrar URL: http://www.cloudflare.com
Updated Date: 2021-01-18T20:11:58Z
Creation Date: 2016-02-17T22:34:56Z
Registry Expiry Date: 2022-02-17T22:34:56Z
Registrar: CloudFlare, Inc.
Registrar IANA ID: 1910
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Name Server: ANGELA.NS.CLOUDFLARE.COM
Name Server: SID.NS.CLOUDFLARE.COM
DNSSEC: unsigned
>>> Last update of whois database: 2021-09-17T05:32:16Z <<<

polycoretherapeutics.com valuation and analysis